JCM Updates on Azithromycin API Export
It is used primarily to treat various bacterial infections caused by respiratory pathogens, such as Aerobic gram-positive microorganisms and Aerobic gram-negative microorganisms. Azi prevents bacterial cells from manufacturing specific proteins ...
MarketWatch - Wed, 16 Apr 2014 18:30

Tuberculosis: treatment and prevention
MTB is a small non-motile, slow-dividing bacillus that stains very weakly “Gram-positive” and can survive in a dry state for weeks. The disease is transmitted by aerosolised droplets expelled primarily by coughing, sneezing and spitting; and the ...
PMLiVE - Thu, 17 Apr 2014 04:16

Timely testing essential to treat bacterial skin, subcutaneous infections
Of these, 66.7% had one bacterium isolated; 25% had two bacterium isolated; and 8.3% had three bacterium isolated. A total of 34 microorganisms were isolated from patients in the study. Half of isolated microorganisms responded to gram-positive ...
Healio - Tue, 01 Apr 2014 12:52

5 notable FDA decisions in 2014
The FDA Anti-Infective Drugs Advisory Committee has voted unanimously that dalbavancin has demonstrated substantial effectiveness and safety for the treatment of acute bacterial skin and skin structure infections caused by certain gram-positive ...
Healio - Wed, 16 Apr 2014 08:29

Through Genomic Analysis, Researchers Untangle Steps Leading to an Epidemic
Group A Streptococcus, a Gram-positive bacterial pathogen, causes some 600 million infections globally each year and an estimated 10,000 to 15,000 severe infections in the United States. Mild illness due to GAS includes strep throat and skin infections ...
GenomeWeb - Mon, 14 Apr 2014 12:22

Stocks Alert- The Medicines Company (MDCO), Peregrine Pharmaceuticals ...
... the investigational intravenous antibiotic, oritavancin, for the treatment of complicated skin and skin tissue infections or cSSTI, caused by susceptible gram-positive bacteria, including by methicillin-resistant Staphylococcus aureus or MRSA ...
Techsonian (press release) - Fri, 18 Apr 2014 03:41

CDC: Hospital Antibiotic Use Promotes Resistance: Checklist Can Improve ...
“We want to develop the infrastructure in every hospital, so every physician knows how to prescribe properly in the context of [his or her] hospital,” said Arjun Srinivasan, MD, associate director for health care–associated infection prevention ...
JAMA_ The Journal of the American Medical Association - Tue, 15 Apr 2014 13:23

Committee Backs Approval of Cubist Antibiotic for Skin Infection
Sivextro is a once-daily oxazolidinone being developed for both intravenous (I.V.) and oral administration for the treatment of serious infections caused by certain Gram-positive bacteria, including those caused by methicillin-resistant Staphylococcus ...
Drug Discovery & Development - Tue, 01 Apr 2014 12:07

FDA Advisory Committee Unanimously Recommends Approval of Dalvance(TM ... (press release) - Tue, 01 Apr 2014 04:37

1  2  3  4  5  6  7  8    ->

Last update: April 2009